Protocatechuic acid attenuates chronic unpredictable mild stress induced-behavioral and biochemical alterations in mice

Eur J Pharmacol. 2021 May 5:898:173992. doi: 10.1016/j.ejphar.2021.173992. Epub 2021 Mar 3.

Abstract

Amelioration of oxidative stress via promoting the endogenous antioxidant system and enhancement of monoamines in brain were the important underlying antidepressant mechanism of protocatechuic acid (PCA). The aim of the present study is to explore the potential antidepressant mechanism(s) PCA in chronic unpredictable mild stress (CUMS) mice. Mice were subjected to CUMS protocol for 4 weeks, and administered with PCA (100 and 200 mg/kg) and fluoxetine (20 mg/kg) for 24 days (from day 8th to 31st). Behavioral (sucrose preference, immobility time, exploratory behavior), and biochemical alterations such as serum corticosterone, brain derived neurotrophic factor (BDNF), inflammatory cytokines, tumor necrosis factor- α (TNF-α), interleukin-6 (IL-6), and antioxidants parameters were investigated. Experimental findings revealed that CUMS subjected mice exhibited significant impairment in behavioral alterations, such as increased immobility time, impaired preference to the sucrose solution, BDNF levels and, serum corticosterone, cytokines, malondialdehyde (MDA) formation with impaired antioxidants in the hippocampus and cerebral cortex. Administration of PCA to CUMS mice attenuated the immobility time, serum corticosterone, cytokines TNF-α, and IL-6, MDA formation and improved sucrose preference, including restoration of BDNF level. Thus, the present findings demonstrated the antidepressant potential of PCA which is largely achieved probably through maintaining BDNF level, and by modulation of the oxidative stress response, cytokines systems, and antioxidant defense system in mice.

Keywords: Antidepressant activity; Chronic unpredictable mild stress; Mice neurobiochemical alterations; Oxidative stress; Protocatechuic acid.

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology*
  • Antioxidants / pharmacology*
  • Behavior, Animal / drug effects*
  • Biomarkers / blood
  • Brain / drug effects*
  • Brain / metabolism
  • Brain / physiopathology
  • Brain-Derived Neurotrophic Factor / blood
  • Chronic Disease
  • Disease Models, Animal
  • Exploratory Behavior / drug effects
  • Food Preferences / drug effects
  • Hydroxybenzoates / pharmacology*
  • Interleukin-6 / blood
  • Male
  • Mice
  • Motor Activity / drug effects
  • Oxidative Stress / drug effects*
  • Stress, Psychological / blood
  • Stress, Psychological / drug therapy*
  • Stress, Psychological / physiopathology
  • Stress, Psychological / psychology
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Antidepressive Agents
  • Antioxidants
  • Bdnf protein, mouse
  • Biomarkers
  • Brain-Derived Neurotrophic Factor
  • Hydroxybenzoates
  • Interleukin-6
  • Tnf protein, mouse
  • Tumor Necrosis Factor-alpha
  • interleukin-6, mouse
  • protocatechuic acid